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Abstract: Respiratory syncytial virus (RSV) is an important human pathogen, which infects
respiratory tract epithelial cells causing bronchiolitis and pneumonia in children and the elderly.
Recent studies have linked RSV matrix (M) ability to self-interaction and viral budding. However,
RSV M has been crystalized both as a monomer and a dimer, and no formal proof exists to date
that it forms dimers in cells. Here, by using a combination of confocal laser scanning microscopy
and bioluminescent resonant energy transfer applied to differently tagged deletion mutants of RSV
M, we show that the protein can self-interact in living mammalian cells and that both the N and
C-terminus of the protein are strictly required for the process, consistent with the reported dimeric
crystal structure.
Keywords: RSV M protein; virus assembly; Bioluminescence resonance energy transfer (BRET);
confocal microscopy
1. Introduction
Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract disease in
infants and young children [1–3], responsible for one-third of deaths resulting from acute lower
respiratory infection in the first year of life [4–6]. RSV also causes severe respiratory tract disease in
immunosuppressed and older adults, leading to substantial annual mortality [7]. There are no vaccines
or antiviral drugs that effectively target RSV despite decades of research [8]. Deeper understanding of
the molecular mechanisms that underlie RSV assembly could pave the way to the identification of new
vaccine/antiviral targets.
RSV is an enveloped virus with a non-segmented negative sense RNA genome and belongs to
the Orthopneumovirus genus of the Pneumoviridae family [9]. The RSV genome is tightly encapsidated
within the nucleocapsid, which is composed of nucleocapsid protein N, the RNA polymerase L and
its cofactor phosphoprotein P, as well as the M2-1 protein. External to the nucleocapsid is a layer of
matrix (M) protein which acts as a bridge between the nucleocapsid and the lipid bilayer envelope.
Embedded in the envelope are the fusion (F), large (G) and small hydrophobic (SH) glycoproteins.
M2-2, NS1 and NS2 proteins are not found in the virion in any significant amount but have important
roles in the RSV replication cycle [10–15].
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M protein is a major structural protein of RSV, playing a central role in virus assembly and
in retaining the intact virion [16]. M interacts with the envelope glycoproteins [17–20], with the
nucleocapsids [21–24] and with the host membrane [19,25,26] to facilitate assembly. M has been
postulated to bring the nucleocapsids and envelope glycoproteins together through its ability to
oligomerise [27,28]. This is an essential assembly step to ensure production of infectious virus.
Previous studies have shown that M readily forms homodimers and self-aggregates in vitro [19,28,29].
Despite the harsh ionic conditions required to isolate M in its monomeric form [19], M was at
first crystallized as a monomer [26] and later shown to form dimers [27], similarly to matrix
proteins from other Mononegavirales, including other Penumoviridae members such as human
Metapneumovirus [27,30–33]. Based on the in vitro data and on observations of mutant M in the
context of infected and transfected cells, it was postulated that M can form oligomers in cells, however
this had not been shown experimentally. Mutations targeting the dimerization interface affected the
ability to form virus-like particles in a co-transfection system, but this did not correlate with loss
of dimerization as assessed by size exclusion chromatography [27], raising the possibility that the
observed phenotype was due to misfolding or aggregation of M.
In this study, we have used confocal laser scanning microscopy (CLSM) and bioluminescent
resonant energy transfer (BRET) in cells transfected to express differently tagged M, to show that M can
self-interact in live cells and that both N and C termini are required for this interaction. Our findings
confirm and extend previous in vitro data on M oligomerization. Importantly, our studies validate the
published structure of the M dimer that predicts a direct interaction between N and C termini of two
monomers to form the dimer [27].
2. Materials and Methods
2.1. Plasmid Construction
Mammalian expression plasmids were generated using the GatewayTM technology (Invitrogen,
Carlsbad, CA, USA). Entry clones pDNR207-M (1–256), pDNR207-M (1–200), pDNR207-M (110–183)
and pDNR207-M (183–256) were generated via BP recombination reactions between PCR products
with attB sites flanking the appropriate coding sequences and plasmid pDNR207 (Life Technologies,
Carlsbad, CA, USA, as described previously [34]), using the full-length codon optimized M gene
cloned into pCDNA3.1 [27] as a template.
Entry clones were used to generate C-terminal yellow fluorescent protein (YFP), cyan fluorescent
protein (CFP) and Renilla luciferase (RLuc) fusion Mammalian expression vectors following LR
recombination reactions with the pDESTnYFP, pDESTnCFP and pDESTnRLuc [35] Gateway compatible
vectors, as described in [36]. All vectors were confirmed by sequencing.
2.2. Cell Culture and Transfections
Human embryonic kidney (HEK)293-A and HEK293-T cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 50 U/mL
penicillin, 50 U/mL streptomycin and 2 mM L-glutamine as described in [37]. For imaging experiments,
cells were trypsinized and 2.5 × 104 HEK293-A cells were seeded onto polylysinated 12 mm glass
coverslips in 24-well plates 1 day before transfection [38]. Each well was transfected with a total of
250 ng of plasmid DNA and 1 µL of lipofectamine 2000 (Thermofisher, Waltham, MA, USA).
For BRET experiments, cells were trypsinized and 1 × 105 HEK293-T cells were seeded onto
24-well plates 1 day before transfection [39]. Each well was transfected with a total of 500 ng of
plasmid DNA and 2 µL of lipofectamine 2000 (Thermofisher). BRET saturation experiments were
performed transfecting cells with 0.5 ng of RLuc-M (1–256) and increasing amounts (0–450 ng) of YFP-M
(1–256). Total DNA amount was normalized to 500 ng total with plasmid pCDNA3.1 (Thermofisher,
Waltham, MA, USA). Importantly, no signs of cell toxicity were observed upon transfection of all M
expression plasmids.
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2.3. Microscopy/CLSM/Image Analysis
Subcellular localization of fluorescently tagged fusion proteins was visualized 24 h and 48 h after
transfection using an inverted epi-fluorescent microscope (Leica, Wetzlar, Germany) equipped with a
40× objective, essentially as described previously [40]. 48 h after transfection, cells were fixed with 4%
paraformaldehyde 15 min at room temperature (RT), before being mounted onto glass coverslips with
FluoromountG (Southern Biotech, Birmingham, AL, USA). When required nuclei where counterstained
with DRAQ5 (Life Technologies, Carlsbad, CA, USA, 1:1000). Samples were processed by confocal
laser scanning microscopy (CLSM) using a Leica TCT-SP2 system, equipped with a Planapo fluor 63×
oil immersion objective (Leica). The Fn/c values were determined using the NIH ImageJ 1.62 public
domain software, from single cell measurements for each of the nuclear (Fn) and cytoplasmic (Fc)
fluorescence, subsequent to the subtraction of fluorescence due to autofluorescence/background as
described previously [41]. Co-localization analysis was performed using the coloc2 plugin. Data were
plotted and analyzed using Prism 6 (GraphPad) software (La Jolla, CA, USA).
2.4. Bioluminescence Resonance Energy Transfer (BRET) Assays
BRET experiments were performed as described in [35]. Briefly, 293T cells were transfected in
24-well plates with appropriate amounts of BRET donor expressing plasmids. For each construct,
the donor (RLuc) expressing plasmid was transfected either in the absence or in the presence of the
relative acceptor (YFP) expressing plasmid to allow calculation of background BRET signal. 48 h
post transfection, culture media was removed from wells and cells were very gently washed with
1 mL of PBS, before being resuspended with 290 µL of fresh PBS. Cells were further resuspended
and 90 µL of mixture were transferred to a black bottomed 96-well plate (Costar®, Washington, DC,
USA, product number 3916) well in triplicate, and signals acquired using a spectrometer compatible
with BRET measurements (VICTOR X2 Multilabel Plate Reader, PerkinElmer, Waltham, MA, USA).
Fluorescent signal (YFPnet) relative to YFP fluorescent emission were acquired using a fluorimetric
excitation filter (band pass 485 ± 14 nm) and a fluorimetric emission filter (band pass 535 ± 25 nm).
Luminometric readings were performed at 5’, 15’, 30’, 45’ and 60’ after addition of the substrate (native
Coelenterazine or Coelenterazine-h, depending on the assay, 5 µM PJK, Kleinblittersdorf, Germany).
Data were acquired for 1 s/well, using a luminometric 535 ± 25 nm emission filter (YFP signal) and a
luminometric 460 ± 25 nm emission filter (RLuc signal). Before reading, the plate was shaken for 1 s
at normal speed and with double orbit. After background subtraction using values relative to mock
transfected cells, the data obtained were used to calculate the BRET signal, defined as the ratio between
the YFP and RLuc signals calculated for a specific BRET pair, according to the formula:
BRET signal =
YFP signal
RLuc signal
Similarly, the BRET ratio, defined as the difference between the BRET value relative to a BRET
pair and the BRET value relative to the BRET donor alone, was calculated according to the formula:
BRET ratio =
YFP signal
RLuc signal
BRET pair− YFP signal
RLuc signal
BRET donor
BRET saturation curves were then calculated using the GraphPad Prism software by plotting
each individual BRET ratio value to the YFPnet/RLuc signal, and interpolating such values using the
one-site binding hyperbola function of GraphPad Prism. Specific BRET pairs generate logarithmic
shaped curves and reach a plateau. This allowed calculation of BRETmax (Bmax) and BRET50 (B50)
values, indicative of maximum energy transfer and relative affinity of the BRET pair tested.
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2.5. Visualization of RSV M crystal structures
PDB file 42V3 was downloaded from the protein data bank website and Molecular graphics
and analyses were performed with the UCSF Chimera package [42]. Chimera is developed by the
Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco
(supported by NIGMS P41-GM103311).
3. Results
3.1. Deletion of N- and C-Terminal Portions of RSV M Affects Protein Subcellular Localization
We aimed to investigate whether M exists as a dimer/oligomer within cells, and which protein
domains are involved in dimerization. We initially analyzed the subcellular localization of several
RSV M deletion mutants as expressed in Mammalian cells when C-terminally fused to YFP and CFP.
Such fusions included: full-length (FL) M (1–256); M (1–200), lacking a C-terminal loop (L5) involved
in formation of dimeric structures by interacting with N-terminal helix H2 and loop L2, as well as
the most extreme C-terminal residues of M nuclear export signal (NES): aas 194–206); M (110–183),
containing only the nuclear localization signal (NLS) and DNA binding domain (DBD) (NLS/DBD,
residues 110–183), along with a α-sheet (S4) involved in protein dimerization by interacting with loop
L5, but lacking all other functional elements; M (183–256), retaining only the C-terminal NES and loop
L5 (Figure 1).
When expressed individually, the proteins differentially distributed within the cells
(Figure 2A,B). YFP-M (1–256) localized mainly in the cytosol, with only very faint nuclear staining
(Fn/c = 0.26 ± 0.12), consistent with the presence of a strong, chromosomal maintenance 1 (CRM-1)
dependent NES, with a punctate pattern reminiscent of ER/Golgi trafficking. The subcellular
localization of YFP-M (1–200) was similar to that of YFP-M (1–256), with the exception that a higher
fraction of the protein localized to the nucleus (Fn/c = 0.38 ± 0.12), and with the fact that the
punctate staining was evident in a lower percentage of cells, most likely due to lower expression levels.
The difference in the nuclear distribution of YFP-M (1–200) compared to FL M is probably due to the
presence of the NLS and the partial loss of the NES (see Figure 1A). Removal of M N-terminal domain
resulted in YFP-M (183–256) localizing mainly to the cytosol (Fn/c = 0.34 ± 0.12), mainly with a diffuse
pattern, consistently with the presence of a functional NES. On the other hand, YFP-M (110–183),
accumulated to the nucleus to higher extent as compared to the other M fusions, in accordance with
the complete deletion of M NESs (Fn/c = 0.9).
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Figure 1. M deletion mutants used in this study (A) Schematic representation of R espiratory syncytial
virus (RSV) matrix (M) deletion mutants used in this study as fused to either YFP, RLuc and cyan
fluorescent protein (CFP). Elements involved in dimerization are shown, based on the nomenclature
used in [26]. L1, loop 1 (aas 63–88); H2, helix 2 and downstream loop (aas 92–105); H3, helix 3 (aas
129–134); S4, sheet 4 (aas 144–163); L5, loop 5 (225–235); NLS/DBD, nuclear localization sequence/DNA
binding domain (residues 110–183); NES, nuclear export sequence (aas 194–206); YFP, yellow fluorescent
protein; RLuc, Renilla luciferase; (B) The recently solved M dimeric structure (PDB code 4V23) was
used to highlight the key aas involved in M dimerization and their position relative to each deletion
mutant tested in this study, using software Chimera as described in the Materials and Methods section.
The surface of a full-length M monomer (1–256) is shown as a grey structure in combination with the M
versions used in this study, shown as red ribbons. Key residues involved in dimerization in the latter
subunit are shown in green. Residue labels are shown either in white or green, depending on their
presence or absence in the corresponding deletion mutant, respectively.
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Figure 2. Deletion of N- and C-terminal portions of RSV M affects protein subcellular localization.
(A) HEK293 A cells were transfected to transiently express the indicated YFP-M fusions. 24 h post
transfection cell nuclei were stained with DRAQ5, and samples processed for confocal laser scanning
microscopy (CSLM) analysis. Representative images relative to cell nuclei (DRAQ5) and M fusions
(YFP-M) are shown on the left and middle panels, respectively. Merged images of the two channels are
shown in the right panels. Scale bars represent 20 µM. (B) Digital images such as those shown in (A)
were quantitatively analyzed using software ImageJ to calculate the Fn/c ratio relative to each fusion
protein, as described in Material and Method section. The mean ± SD relative to at least 75 cells from 2
independent experiments is shown. The dotted line represents Fn/c of 1, corresponding to an even
distribution between the nucleus and the cytoplasm.
3.2. Deletion of N- and C-Terminal Portions of RSV M Affects M’s Ability to Colocalize with
Full-Length Protein
We decided to investigate whether the elements involved in dimer formation in vitro [27] were
required for M self-interaction in cells. To this end, we expressed CFP-M (1–256) in the presence
or in the absence of the M deletion mutants as fused to YFP and investigated the ability of each
fusion protein to co-localize, as well as to reciprocally affect each other’s subcellular localization.
As expected, expression of CFP-M (1–256) resulted in a mainly cytosolic protein, occasionally showing
a punctate pattern within the cytosol (Fn/c = 0.28 ± 12). Our data indicate that co-expression between
CFP-M (1–256) and all YFP-M mutants tested in this study did not affect their reciprocal subcellular
localization, as compared to when expressed individually (see Figure 3A–C).
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Figure 3. Deletion of N- and C-terminal portions of RSV M affects protein ability to colocalize with
full-length protein. (A) HEK293 A cells were transfected to transiently express the CFP-M (1–256) fusion
protein either in the absence or in the presence of the indicated YFP-M fusions. 24 h post transfection
cell nuclei were stained with DRAQ5 and cells processed for CSLM analysis. Representative images
relative to cell nuclei (DRAQ5), CFP (CFP-M) and YFP-RSV M fusions (YFP-M) are shown, along with
merged images of the three channels (merge). A RGB profile plot relative to the section highlighted
in the merge channel is shown on the right panels; (B) Digital images such as those shown in (A)
were quantitatively analyzed using software ImageJ to calculate the Fn/c ratio relative to each of the
indicated YFP fusion protein, either expressed alone (black columns) or in the presence of CFP-M
(1–256) (white columns). n ≥ 63 from at least two independent experiments; (C) Digital images such
as those shown in (A) were quantitatively analyzed using software ImageJ to calculate the Fn/c ratio
relative to CFP-M (1–256), either expressed alone (black columns) or in the presence of (white columns)
of each of the indicated YFP fusion protein. Red dots indicate the Fn/c ratio relative to the indicated
YFP-M fusions. n ≥ 63 from at least two independent experiments; (D) Images such as those shown in
(A) were used to calculate the Pearson’s coefficient relative to each protein pair. n ≥ 19 from at least
two independent experiments. Scale bars represent 20 µM.
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Furthermore, while clear co-localization between CFP-M (1–256) and YFP-M (1–256) was observed
in cytosolic dots (see Figure 3A,D; Pearson 0.68), such phenomena were not observed between CFP-M
(1–256) and neither YFP-M (1–200) nor YFP-M (110–183), suggesting that the M deletion mutants tested
are not capable of interacting with M (1–256) and affecting its subcellular localization. This hypothesis
is also supported by the evidence that these deletions affected the Pearson colocalization coefficient
with CFP-M (1–256), although to different extents (Figure 3D). Limited colocalization of YFP-M
(183–256) with CFP-M (1–256) was observed in cytosolic dots (Figure 3A, compare the localization of
CFP-M and YFP-M in cytosolic dots, bottom images) with a Pearson’s coefficient comparable to that
between CFP-M (1–256) and YFP-M (1–256) (Figure 3D).
3.3. RSV M Can Self-Interact in Living Cells
Our results suggest that deletion of M C- or N-terminal domain affects its ability to self-interact in
a cellular context. However, they do not prove that the full-length protein is able to self-interact or that
the C-terminal of the protein is able to interact with the full-length protein. Indeed, the co-localization
observed between CFP and YFP tagged versions of full-length M may simply reflect the fact that
tagging M with such spontaneously fluorescent proteins does not affect its subcellular localization,
so that both CFP- and YFP-tagged version of M localize in the same area of the cell. We directly
addressed this issue by bioluminescent energy resonant energy transfer (BRET) assays. To this end,
BRET saturation experiments were performed by transfecting HEK293-T with a fixed amount of BRET
DONOR plasmid RLuc-M (1–256; 0.5 ng) in the presence of increasing amounts of BRET ACCEPTOR
plasmid YFP-M (1:256; 0–450 ng). As a positive control and a reference for data normalization, a fusion
protein between RLuc and YFP (RLuc-YFP) was also expressed, and RLuc and YFP were individually
co-expressed as a negative control (Figure 4A).
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the RLuc-YFP fusion generated a BRET ratio of 0.34 ± 0.02 (Figure 4A), while the RLuc and YFP 
protein, generated a BRET ratio of 0. Importantly, co-expression of RLuc-M (1–256) and YFP-M (1–
256) generated a BRET ratio which rapidly increased with the ratio between YFP-M (1–256) and RLuc-
M (1–256) expression levels (Figure 4A), and which quickly reached saturation. Data fitting allowed 
us to calculate the Bmax, corresponding to the maximal BRET ratio obtainable for the BRET pair (0.43 
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We next used BRET assays to evaluate the ability of M deletion mutants to self-interact and to 
form complexes with the full-length protein. To this end, HEK293-T cells were transfected with a 
series of plasmids encoding the above described M deletion mutants fused to RLuc, either in the 
absence or in the presence of YFP-M expressing plasmids. Each RLuc-M derivative was expressed in 
the presence of its YFP-tagged version, or in the presence of YFP-M (1–256). 48 h post transfection 
cells were processed for BRET assays to monitor protein self-interaction. As expected, we could 
calculate a strong BRET signal (0.55 ± 0.03) relative to the RLuc-M (1–256)/YFP-M (1–256) BRET pair 
(Figure 4B), consistent with the fact that full-length M is capable of self-interacting in living 
mammalian cells. However, very weak BRET signals were calculated for the RLuc-M (1–200)/YFP-M 
(1–200), RLuc-M (110–183)/YFP-M (110–183) and RLuc-M (183–256)/YFP-M (183–256) BRET pairs 
(0.03, 0.04, 0.06, respectively, see Figure 4B, black bars), indicating both N- and C-terminal domains 
Figure 4. RSV M can self-interact in live Mammalian cells, depending on its N and C-terminal
domains. (A) HEK293T cells were transfected to transiently express the RLuc-M (1–256) plasmid
(0.5 ng) either in the absence or in the presence of increasing amounts the YFP-M (1–256) plasmid
(range 0–450 ng). Alternatively, cells were transfected with the positive control plasmid RLuc-YFP
(225 ng) or with plasmid RLuc-M (1–256) and pCMVFLAG-X-YFP as negative controls. 48 h later
cells were processed for BRET measurements as described in the Materials and Methods section.
The BRET ratio relative to the RLuc-M (1–256) and the YFP-M (1–256) BRET pair was plot d against
the normalized YFPNet/RLuc ratio, and data used to calculate the Bmax and B50. The red dotted
line indicates the BRET ratio obtained for the RLuc-YFP control protein, and the blue dotted line
indicates the BRET ratio obtained for the RLuc-M (1–256) protein expressed in the presence of YFP
alone. Representative data from four independent experiments are shown; (B) HEK293T cells were
transfected to transiently express the RLuc-M expression plasmids either alone or in the presence of
the indicated YFP-M expression plasmids. 48 h later cells were processed for BRET measurements as
described in the Materials and Methods section. The BRET ratio relative to each condition is shown.
Representative data from two independent experiments are shown.
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At 48 h post transfection, YFP fluorescent and BRET signals were acquired in living cells, and BRET
ratios calculated, as described in the Materials and Methods section. Our results indicate that the
RLuc-YFP fusion generated a BRET ratio of 0.34 ± 0.02 (Figure 4A), while the RLuc and YFP protein,
generated a BRET ratio of 0. Importantly, co-expression of RLuc-M (1–256) and YFP-M (1–256)
generated a BRET ratio which rapidly increased with the ratio between YFP-M (1–256) and RLuc-M
(1–256) expression levels (Figure 4A), and which quickly reached saturation. Data fitting allowed
us to calculate the Bmax, corresponding to the maximal BRET ratio obtainable for the BRET pair
(0.43 ± 0.04) and the B50, corresponding to the ratio between YFP-M (1–256) and RLuc-M (1–256)
sufficient to generate a BRET ratio corresponding to half of the Bmax (48.4 ± 13.7). Overall, our results
indicate that RLuc-M and YFP-M can interact with high affinity in live mammalian cells.
3.4. Deletion of N- and C-Terminal Portions of RSV M Affects Protein Ability to Form Dimers in Living Cells
We next used BRET assays to evaluate the ability of M deletion mutants to self-interact and to
form complexes with the full-length protein. To this end, HEK293-T cells were transfected with a
series of plasmids encoding the above described M deletion mutants fused to RLuc, either in the
absence or in the presence of YFP-M expressing plasmids. Each RLuc-M derivative was expressed in
the presence of its YFP-tagged version, or in the presence of YFP-M (1–256). 48 h post transfection cells
were processed for BRET assays to monitor protein self-interaction. As expected, we could calculate a
strong BRET signal (0.55 ± 0.03) relative to the RLuc-M (1–256)/YFP-M (1–256) BRET pair (Figure 4B),
consistent with the fact that full-length M is capable of self-interacting in living mammalian cells.
However, very weak BRET signals were calculated for the RLuc-M (1–200)/YFP-M (1–200), RLuc-M
(110–183)/YFP-M (110–183) and RLuc-M (183–256)/YFP-M (183–256) BRET pairs (0.03, 0.04, 0.06,
respectively, see Figure 4B, black bars), indicating both N- and C-terminal domains of M are required
for homodimerization. Similarly, weak BRET signals were generated when the RLuc deletion mutants
were expressed in the presence of full-length YFP-M (1–256), indicating that N- and C-terminal deletion
mutants of M are not capable of interacting with full-length M in living cells (Figure 4B, white bars).
4. Discussion
The data presented in the current study shows that the RSV M protein can self-interact when
expressed in living mammalian cells. Our study confirms in cell culture the self-interaction of M,
previously shown by a number of studies reporting its ability to form homodimers and higher order
oligomers in vitro [19,28,29], highlighting the physiological relevance of the in vitro observations.
Our discovery that this interaction in a cellular context requires both the N and C terminal
domains of the protein is consistent with a recently reported head to tail dimeric structure of M,
whereby the N-terminal domain of one subunit interacts with the C-terminal domain of the other
subunit [27], and is in contrast with initially resolved monomeric M structure [26].
When transiently expressed in mammalian cells as YFP-M fusions, full-length M and its deletion
mutants localized to the expected cellular compartment, depending on the presence or the absence of
M NES and NLS, thus confirming and validating our previous work defining the nuclear transport
motifs of M (see Figure 2; [43,44]). Importantly, YFP-M (1–200), lacking two leucine residues belonging
to M NES (residues 194–206), localized significantly more in the nucleus than FL YFP-M. As expected,
YFP-M (110–183), lacking the NES but bearing the NLS was present equally within the nucleus and the
cytoplasm as has been shown previously, while YFP-M (183–256) that has the NES but lacks the NLS,
was cytoplasmic [43].
Subcellular localization and co-localization analysis upon co-expression of CFP-M (1–256) with
YFP-M (1–256) or its deletion mutants suggested that CFP-M (1–256) does not likely interact with any
of the deletion mutants, with the possible exception of YFP-M (183–256), as indicated by the drop in
co-localization (see Figure 3D). Furthermore, the subcellular localization of CFP-M (1–256) and YFP-M
(110–183) was not affected upon co-expression, with the former remaining mainly cytosolic and the
latter equally distributing between the cytoplasm and the nucleus (see Figure 3A–C). In contrast, YFP-M
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(183–256) partially co-localized with CFP-M (1–256), thus implying potential interaction between the
two proteins. However, the co-localization observed likely reflects their presence in the same location
and not necessarily an interaction (see below). Interestingly, YFP-M (1–200) formed cytoplasmic
inclusion bodies (IBs) that look very similar to those formed by the CFP-M (1–256), yet when the two
proteins were co-expressed, they did not co-localize. Expression of YFP- and CFP- fused deletion
mutants also suggested that M (1–200) and M (183–256) may be able to self-interact as they formed IBs
when expressed in living cells.
BRET analysis in living cells clearly showed that full-length M is very effective in forming dimers
in living cells (see Figure 4A). However, none of the deletion mutants analyzed in our study were able to
self-interact (see Figure 4B). This suggests that the observed IBs are formed due to aggregation that may
be brought about by misfolding of the proteins. However, massive misfolding of the M mutants tested
in our study is unlikely, since similar deletion mutants (containing M aas 1–144, 114–256 and 1–110),
still interact with viral nucleocapsids to similar levels as the full-length protein [22]. Furthermore,
RSV M (110–183) has been shown to inhibit host cell transcription to similar levels as compared to the
full-length protein (Ghildyal et al., unpublished observations [45]). Our data is consistent with the M
dimer being formed by the head to tail interaction of the subunits. In addition, none of the deletion
mutants were able to dimerize with the full-length M (see Figure 4). This finding is consistent with the
structure of the M dimer, which has a very large interface [27].
The dimerization interface comprises residues 63 to 68, 92 to 105, 129 to 134, 144, 163, 225 to 235,
while residue T205 likely modulates M oligomerization in a phosphorylation dependent manner [27].
Our data shows that all the residues are needed to form a stable dimer, consistent with previous
work, which demonstrated that mutation of single residues in the context of the full-length protein
has an observable effect on the filament formation and dimerization/oligomerization behavior of
M [27]. Clearly, there are complex interactions with several residues in the dimerization interface
with each having a specific role in stabilizing the structure. Since point mutations destabilizing
RSV M self-interaction in vitro also negatively affected viral budding, it is reasonable to consider M
dimerization as an attractive potential target for the development of antiviral agents. In this context,
the BRET-based assay described here to monitor M self-interaction might provide a valuable tool for
screening of compounds interfering with M self-interaction, or for the validation of hits identified by
other methods [35,46–48].
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